| Product NDC: | 64067-216 | 
| Proprietary Name: | UVADEX | 
| Non Proprietary Name: | Methoxsalen | 
| Active Ingredient(s): | 20 ug/mL & nbsp; Methoxsalen | 
| Administration Route(s): | EXTRACORPOREAL | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 64067-216 | 
| Labeler Name: | Therakos, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020969 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19990225 | 
| Package NDC: | 64067-216-01 | 
| Package Description: | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS | 
| NDC Code | 64067-216-01 | 
| Proprietary Name | UVADEX | 
| Package Description | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS | 
| Product NDC | 64067-216 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Methoxsalen | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | EXTRACORPOREAL | 
| Start Marketing Date | 19990225 | 
| Marketing Category Name | NDA | 
| Labeler Name | Therakos, Inc. | 
| Substance Name | METHOXSALEN | 
| Strength Number | 20 | 
| Strength Unit | ug/mL | 
| Pharmaceutical Classes | Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient] |